Katherine N. Cahill - Concepedia

Author

Katherine N. Cahill

Brigham and Women's Hospital ORCID

Also Known As

K Cahill, K. Cahill, K.N. Cahill, Katherine Cahill, Katherine N Cahill, Katherine N. Cahill

147

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Vanderbilt University Medical Center Vanderbilt University VA Tennessee Valley Healthcare System

About

Katherine N. Cahill is an author at Brigham and Women's Hospital specializing in medicine, allergy, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.6K
2	Allergy	13	14	1.3K
3	Public Health	2	2	39
4	Arts	1	1	14
5	Epidemiology	1	1	43

Katherine N. Cahill

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Allergic inflammatory memory in human respiratory epithelial progenitor cells José Ordovás-Montañés, Daniel F. Dwyer, Sarah K. Nyquist, Nature AsthmaInflammationAllergyInflammatory Lung DiseaseLung Inflammation	2018	564
Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease Katherine N. Cahill, Jillian C. Bensko, Joshua A. Boyce, Journal of Allergy and Clinical Immunology AsthmaInflammationAnti-inflammatoryAllergyInflammatory Lung Disease	2014	226
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies David E. E. Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti, The Journal of Allergy and Clinical Immunology In Practice Preclinical Drug EvaluationMedicinePharmacologyMonoclonal AntibodiesPharmacotherapy	2016	202
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma Katherine N. Cahill, Howard R. Katz, Jing Cui, New England Journal of Medicine	2017	202
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease Kathleen M. Buchheit, Katherine N. Cahill, Howard R. Katz, Journal of Allergy and Clinical Immunology InflammationCytokineD2 GenerationInflammatory Lung DiseaseAllergy	2015	180
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists Dinah Foer, Patrick E. Beeler, Jing Cui, American Journal of Respiratory and Critical Care Medicine	2020	131
Glucagon‐like peptide‐1 receptor agonist inhibits aeroallergen‐induced activation of ILC2 and neutrophilic airway inflammation in obese mice Shinji Toki, Dawn C. Newcomb, Richard L. Printz, Allergy	2021	72
Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease Katherine N. Cahill, Benjamin A. Raby, Xiaobo Zhou, American Journal of Respiratory Cell and Molecular Biology	2015	69
Inflammatory heterogeneity in aspirin-exacerbated respiratory disease William C. Scott, Katherine N. Cahill, Ginger L. Milne, Journal of Allergy and Clinical Immunology AsthmaInflammationInflammatory Lung DiseaseAllergyLung Inflammation	2020	65
Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial Katherine N. Cahill, Jing Cui, Parul H. Kothari, American Journal of Respiratory and Critical Care Medicine	2019	53

Page 1